JPMorgan Chase & Co. news

   Watch this stock
Showing stories 1 - 10 of about 163   

Articles published

JPM 61.58 +0.44 (0.72%)
price chart
JPMorgan Chase & Co. Sticks To Anti-Splitting Stance
Many analysts have suggested JPMorgan Chase & Co. (NYSE:JPM) to split up into smaller entities, as the bank faces increased scrutiny due to its size and complexity.
JPMorgan Chase & Co. PT Raised to $68.00 at Argus (JPM)  sleekmoney
DineEquity Downgraded by JPMorgan Chase & Co. (DIN)  Dakota Financial News
JPMorgan Chase & Co. Announces 1 Million Plus Apple Inc. Pay Users
JPMorgan Chase & Co. (NYSE:JPM) had its 2015 Investors Day on Tuesday, where it announced that over a million customers are making transactions with their credit and debit cards through Apple Pay.
JPMorgan Chase (JPM) Stock Rising Today Following Higher Price Target
"We rate JPMORGAN CHASE & CO (JPM) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate.
JPMorgan Chase & Co. Given "Buy" Rating at Deutsche Bank (JPM)  Dakota Financial News
JPMorgan eyes $1.4 billion in cost savings in 2015  Reuters
Closter murder-suicide latest JPMorgan Chase & Co. worker death
CLOSTER -- A JPMorgan Chase & Co. employee and his wife were found dead in their home in an apparent murder-suicide. It happened in Closter Friday evening, where the bodies of Michael and Iran Pars Tabacchi were discovered.
New Jersey man Michael Tabacchi 'killed himself and wife in murder ...  Daily Mail
Petrobras Scandal News: Oil Company Reportedly Hires JPMorganChase & Co ...
Brazil's state-controlled oil producer, Petr´┐Żleo Brasileiro SA, commonly known as Petrobas, has hired JPMorgan to handle $3 billion in planned asset sales this year.
JPMorgan Chase & Co. Raises bluebird bio Price Target to $117.00 (BLUE)
bluebird bio logo Research analysts at JPMorgan Chase & Co. lifted their target price on shares of bluebird bio (NASDAQ:BLUE) from $103.00 to $117.00 in a report released on Thursday.
bluebird bio Price Target Raised to $117.00 at JPMorgan Chase & Co. (BLUE)  Mideast Time
Cott Price Target Raised to $10.25 at JPMorgan Chase & Co. (COT)
Cott (NYSE:COT) had its price target upped by JPMorgan Chase & Co. from $7.25 to $10.25 in a research note issued to investors on Thursday.
JPMorgan Chase & Co. Raises Cott Price Target to $10.25 (COT)  Mideast Time
JPMorgan Chase & Co. Initiates CSX Corporation Coverage With An Overweight ...
J.P. Morgan analyst, Brian Ossenbeck, stated that CSX Corp is well-matched with the sell-side firm's adverse coal sector viewpoint.
JPMorgan Chase & Co. Increases BioMarin Pharmaceutical Price Target to ...
BioMarin Pharmaceutical logo Research analysts at JPMorgan Chase & Co. boosted their price objective on shares of BioMarin Pharmaceutical (NASDAQ:BMRN) from $110.00 to $120.00 in a report released on Thursday.
BioMarin Pharmaceutical Price Target Increased to $120.00 by Analysts at ...  The Legacy
BioMarin Pharmaceutical Given New $133.00 Price Target at Citigroup Inc ...  WKRB News
JPMorgan & Chase Co. Under Investigation Over Auto-Loan Lending Practices
JP Morgan Chase & Co. has been investigated by the US Department of Justice, the bank said on Tuesday. In an annual filing with the Securities and Exchange Commission (SEC), the largest US bank said that it is being scrutinized over lending practices.